Deal done with Medtronic. Real coup to do a deal with such a massive US company. US$71.4 billion market cap. This is a big deal. Medtronic only got the rights to the heart applications. All the orthopedic stuff, XBL retain rights over, so... Expect: 1. Roadshow to major analysts and instos. (MD is ex Metabolic Circadian and Axon so has contacts and cred) 2. Deals on the orthopedic applications. 3. Potential spin-off company
This thing is ridiculously cheap given its potential and given independent validation of its technology by MEd.
XBL Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
